Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ACAD
Nasdaq
2834
http://www.acadia-pharm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ACADIA Pharmaceuticals Inc.
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
- Dec 6th, 2019 12:39 pm
A 60% Tumble for Sage Therapeutics, and Two More Numbers to Know
- Dec 6th, 2019 10:00 am
Hedge Funds Snapped Up ACADIA Pharmaceuticals Inc. (ACAD) Before The Q4 Rally
- Dec 6th, 2019 4:01 am
Why This Highflying Biotech Stock Zoomed Near A Profit-Taking Zone
- Dec 5th, 2019 9:08 pm
Biotech Stocks Are Making Wild Moves Amid a Deluge of Trial Data
- Dec 5th, 2019 3:08 pm
The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
- Dec 5th, 2019 12:14 pm
Acadia Pharma's psychosis drug proven better than placebo in dementia patients
- Dec 5th, 2019 1:45 am
ACADIA Pharmaceuticals Presents Positive Top-line Results from Pivotal Phase 3 HARMONY Trial of Pimavanserin in Patients with Dementia-Related Psychosis at 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
- Dec 5th, 2019 1:45 am
7 Exciting Biotech Stocks to Buy Now
- Dec 2nd, 2019 7:57 pm
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
- Dec 1st, 2019 2:30 pm
3 Monster Growth Stocks That Are Still in the Buy Zone
- Dec 1st, 2019 12:27 pm
What Makes Acadia Pharmaceuticals (ACAD) a Strong Momentum Stock: Buy Now?
- Nov 27th, 2019 3:00 pm
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
- Nov 25th, 2019 9:03 pm
Top Ranked Momentum Stocks to Buy for November 25th
- Nov 25th, 2019 1:58 pm
The Medicines Company Soars Amid Acquisition Whispers
- Nov 21st, 2019 2:56 pm
Medtronic (MDT) to Report Q2 Earnings: What's in Store?
- Nov 18th, 2019 3:17 pm
The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and Celgene
- Nov 12th, 2019 1:18 pm
IBD Stock Of The Day Breaks Out As It Stares Down A Massive Opportunity
- Nov 11th, 2019 9:48 pm
4 Biotech Stocks That Could Keep Beating Wall Street
- Nov 11th, 2019 2:28 pm
Scroll